Evidence map›Paper›PMID 31024785›Full record

ArticlePhilosophy & technology2019

Big Data Analytics, Infectious Diseases and Associated Ethical Impacts.

Chiara Garattini, Jade Raffle, Dewi N Aisyah, Felicity Sartain, Zisis Kozlakidis

Open access · hybridAbstract read
In one paragraph

Article in Philosophy & technology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Human mobility and the infectious disease transmission: A systematic review.Geo-spatial information science = Diqui kongjian xinxi kexue xuebao · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Digital microbiology.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Chiara Garattini1Anthropology and UX Research, Health and Life Sciences, Intel, London, UK.
Jade Raffle2Division of Infection and Immunity, University College London, Cruciform Building, Gower Street, London, WC1E 6BT UK.
Dewi N Aisyah3Department of Infectious Disease Informatics, University College London, Farr Institute of Health Informatics Research, 222 Euston Road, London, NW1 2DA UK.
Felicity SartainProfiscio Ltd., 10 Great Russell Street, London, WC1B 3BQ UK.
Zisis Kozlakidis2Division of Infection and Immunity, University College London, Cruciform Building, Gower Street, London, WC1E 6BT UK.ORCID 0000-0002-3836-7209
University College London · GBFarr Institute · GBIntel (United Kingdom) · GBShell (United Kingdom) · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

The exponential accumulation, processing and accrual of big data in healthcare are only possible through an equally rapidly evolving field of big data analytics. The latter offers the capacity to rationalize, understand and use big data to serve many different purposes, from improved services modelling to prediction of treatment outcomes, to greater patient and disease stratification. In the area of infectious diseases, the application of big data analytics has introduced a number of changes in the information accumulation models. These are discussed by comparing the traditional and new models of data accumulation. Big data analytics is fast becoming a crucial component for the modelling of transmission-aiding infection control measures and policies-emergency response analyses required during local or international outbreaks. However, the application of big data analytics in infectious diseases is coupled with a number of ethical impacts. Four key areas are discussed in this paper: (i) automation and algorithmic reliance impacting freedom of choice, (ii) big data analytics complexity impacting informed consent, (iii) reliance on profiling impacting individual and group identities and justice/fair access and (iv) increased surveillance and population intervention capabilities impacting behavioural norms and practices. Furthermore, the extension of big data analytics to include information derived from personal devices, such as mobile phones and wearables as part of infectious disease frameworks in the near future and their potential ethical impacts are discussed. Considered together, the need for a constructive and transparent inclusion of ethical questioning in this rapidly evolving field becomes an increasing necessity in order to provide a moral foundation for the societal acceptance and responsible development of the technological advancement.

Indexed as

Big data analyticsEthicsInfectious diseasesMobile phonesWearables

Identifiers

PMID31024785
PMCPMC6451937
OpenAlexW2747480872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.